Visikol is a contract research organization specializing in digital pathology, 3D tissue imaging, and 3D cell culture assays, providing pharmaceutical and biotech companies with tools to enhance drug discovery efficiency. Their services enable researchers to obtain critical insights into drug efficacy and safety, reducing the time and cost associated with traditional development processes.
Funding
$1.6M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Pharmaceutical and biotech companies face challenges in efficiently assessing drug efficacy and safety due to limitations in traditional drug discovery processes. Conventional methods often lack the complexity needed to accurately predict in vivo outcomes, leading to increased time and costs in drug development.
Solution
Visikol provides contract research services specializing in advanced cell culture assays and tissue imaging to enhance drug discovery. The company offers a suite of services, including digital pathology, 3D tissue imaging, and 3D cell culture assays, designed to provide critical insights into drug efficacy and safety. Visikol's services utilize advanced imaging and cell culture tools to ensure drugs fail faster during the discovery process, enabling researchers to answer more complex research questions. By working closely with clients as an extension of their R&D teams, Visikol offers both standard assays and custom development projects to accelerate the drug discovery process.
Target Audience
Visikol serves pharmaceutical and biotech companies seeking advanced imaging and cell culture tools to accelerate drug discovery and development.
Features
- In vitro blood-brain barrier permeability assessment using a novel BBB model and LCMS/MS analysis
- HUREL® Micro Livers, self-assembling co-cultures of primary hepatocytes for DMPK studies
- Highly multiplexed immunohistochemistry services for biomarker profiling of tissues with 10+ markers on a single slide
- In vitro immuno-oncology immune cell infiltration assay using 3D cell culture models
- Liver fibrosis assay using 3D cell culture models and qPCR analysis
- In Vitro Antibody Pharmacokinetics Assay that measures the distribution of biologicals, including antibody drugs, into solid tumor models
- Cleared tissue 3D imaging and analysis services
- Digital pathology services